Document is current

Article History

Received: 20 December 2024

Accepted: 10 March 2025

First Online: 5 April 2025

Declarations

:

: The appropriate institutional review boards and ethics committees have approved the study:University Health Network Research Ethics Board, Toronto, Ontario, Canada; WCG IRB, Princeton, New Jersey, USA; Biomedical Research Alliance of New York, Lake Success, New York, USA; Human Subjects Protection Program Office, Louisville, Kentucky, USA; SM3-Sud-Méditerranée III, CHU de Nîmes Place du Professeur.

: DE is a paid consultant of Medtronic and has received a speaker honorarium from Medtronic. MM has received grant(s), a speaking honorarium and is a paid consultant of Medtronic. RK has received grant(s), a speaking honorarium, support for attending meetings and/or travel and is a paid consultant of Medtronic and Axonics. RL is a member of an institutional data safety monitoring board (unrelated to this study). JY is an unpaid member of the American Urogynecologic Society Finance Committee, and is a paid consultant for Medtronic, Locus, Myovant, and Conoceptra. JB has received compensation for a teaching course for Medtronic. JM has received a speaking honorarium and is a paid consultant of Medtronic. KX is a paid consultant of Medtronic. MW and BP are employees of Medtronic. IP, RF, and LS do not have any additional disclosures.